07 Jan 2001

Medivitan® N-Ampullen (Medivitan® N-Ampullen/ -Fertigspritze Injektionslösung) - Deutschland

Updated: 07 Jan 2001

Medivitan® N-Ampullen | -Fertigspritze

Vitaminmangelzustände: Anämien, periphere Neuropathien, Kachexie. Erhöhter Vitaminbedarf: Lebererkrankungen Alkoholabusus, Magen-/Darmresektion, Strahlenbehandlung, Chemotherapie, antibiotische Therapie.

Medivitan® N-Ampullen Description, Presentation and Dosage

Medivitan® N-Ampullen Description

Medivitan® N-Ampullen Drug Class Description

Kombinationen mit Vitaminen u. anderen Stoffen

Medivitan® N-Ampullen Drug Description

4 ml (Lsg. I) enth.: Hydroxocobalamin (Vit.-B12-Depot) 1000 µg, Pyridoxin-HCl 5 mg, als Lokalanästhetikum Lidocain-HCl H2O-frei 24 mg.

Medivitan® N-Ampullen Generic Name

Medivitan® N-Ampullen/ -Fertigspritze Injektionslösung

Medivitan® N-Ampullen Presentation

Medivitan® N-Ampullen Presentation

Medivitan® N-Ampullen/-Fertigspritze

Medivitan® N-Ampullen Manufacturer


Related Learning Zones

Cystic Fibrosis Knowledge Centre

Cystic Fibrosis Knowledge Centre

Cystic fibrosis (CF) is a genetic condition caused by a defect in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel. The Cystic Fibrosis Knowledge Centre provides healthcare professionals with access to disease awareness information, emerging and established treatment options and current best practice based on recently updated guidelines by the European Cystic Fibrosis Society (ECFS). A resources section contains external links to upcoming medical conferences and patient support groups.

This resource is developed by EPG Health Media for epgonline.org, supported by an independent educational grant from Vertex.

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis is intended for healthcare professionals involved in the treatment and management of patients with psoriasis. This resource has been developed primarily to discuss the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A. Users can expect to find sections containing expert videos, clinical slide decks, congress highlights, key publications and links to useful resources.

This resource has been developed in collaboration with Novartis Pharma AG.

Medivitan® N-Ampullen Dosage

Medivitan® N-Ampullen Adult Dosage

Wasser f. Inj.-zwecke.

Medivitan® N-Ampullen Precautions, Reactions and Contraindications

Medivitan® N-Ampullen Special Precautions

Medivitan® N-Ampullen Special Precautions

L 60

Related Drugs -

Back to top